Assessment of occupationally exposed organic solvents and welding fumes induced DNA damage and SNPs (PARK13, LRRK2 and CAST gene) and risk of Parkinson’s disease
Objective: The aim of this study was to examine the potential association between solvents, welding fumes and SNPs and risk of developing PD. Background: The…A case of osmotic demyelination syndrome presenting parkinsonism affected by blood alcohol concentration change
Objective: To describe a patient with osmotic myelinolysis caused by change in blood alcohol level who developed acute parkinsonism. Background: Osmotic myelinolysis is an acute,…Genetics and phenotypes of recessive parkinsonism in French and North African populations
Objective: To evaluate the mutation frequency in recessive genes and the associated phenotype in a large series of French and North African cases with Parkinson’s…Acute parkinsonism following an obstructive hydrocephalus and a ventriculoperitoneal shunt revision: a case report
Objective: To describe a case of acute parkinsonism following an obstructive hydrocephalus and ventriculoperitoneal (VP) shunt revision. Background: Acute parkinsonism is a rare complication of…The role of the gut microbial dysbiosis and serum inflammatory profile for the discrimination of clinical subtypes in Parkinson’s disease
Objective: To investigate whether clinical phenotypes can be predicted by the assessment of gut microbiome and serum inflammatory profile of PD patients. Background: Recent evidence…Special features of parkinsonism with congenital anomalies of cerebral vessels
Objective: To study the features of the flow of parkinsonism with congenital anomalies of cerebral vessels. Background: Analysis of the study of neurological status, data…Liquid Levodopa/Carbidopa – An underutilized, cost effective treatment of advanced Parkinson’s disease in the developing world
Objective: Advanced Parkinson’s disease manifests with “on-off” phenomenon, dyskinesias and increasing symptom severity . Managing it in developing countries is difficult given the low per…The Progressive Supranuclear Palsy Functional Disability Scale: Sensitivity to change
Objective: To determine the sensitivity to change within 12 months as well as completion time of the Progressive Supranuclear Palsy Functional Disability Scale (PSPFDS). Background:…Validation of the Movement Disorder Society criteria for the diagnosis of 4R-tauopathies
Objective: To validate the accuracy of the newly proposed Movement Disorder Society diagnostic criteria for progressive supranuclear palsy (MDS-PSP criteria, Höglinger et al., 2017) to…Stereopsis as a Visual Biomarker for Parkinson’s Disease
Objective: 1): To assess Parkinson’s disease (PD) patients’ stereopsis function using better and more physiologically meaningful tools; 2): To reveal specific eye behaviors of stereoacuity…
- « Previous Page
- 1
- …
- 144
- 145
- 146
- 147
- 148
- …
- 217
- Next Page »